Deborah is a nationally recognized leader in health industry transactions, focusing on complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.
Deborah’s recent health industry merger and acquisition activity includes acquisitions and sales, joint ventures, and strategic affiliations totaling over one billion dollars. Her clients span the health care spectrum, including providers of ambulatory surgery services, physician networks, kidney care services, vision care services, radiology and teleradiology services, micro-hospital development and management services, home care services, fertility services, population health management and value based care, substance use disorder treatment, and behavioral health services. Deborah has extensive project management experience, and provides deal structuring, general counseling, regulatory advice, and strategic planning for both nonprofit and for-profit health care providers.
Deborah is a Member in the firm's Health Law Practice. She is also a member of the firm's Health Reform Working Group and has served on the Policy Committee.
Deborah is also a certified Pilates instructor.
Deborah is a nationally recognized leader in health industry transactions, focusing on complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.
Experience
- Represented a Fortune 250 company that is a leading provider of kidney care and the country's largest operator of physician networks in hundreds of acquisitions, sales, and joint ventures nationwide.
- Represented a private equity backed radiology services provider in multiple practice acquisitions.
- Represented multiple clients in developing population health management solutions
viewpoints
Health Care Deal Structures: What Will the Deal Look Like?
February 15, 2023 | Blog | By Pamela Polevoy, Deborah Daccord, Cody Keetch
Mintz Health Law: What We Are Grateful For
January 11, 2023 | Podcast | By Bridgette Keller
Removing Barriers to Second Chances
January 24, 2022 | Article
Health Law Diagnosed — Mintz’s 2022 Health Law New Year’s Resolutions
January 12, 2022 | Podcast | By Bridgette Keller
363 Sales as a Health Care M&A Tool, Part 2 – Pros and Cons for Buyers and Sellers
September 11, 2020 | Blog | By Deborah Daccord, William Kannel, Tim McKeon
As a refresher, a 363 Sale couples a flexible and fast process with ample liability protection for willing buyers. The primary benefit of a 363 Sale is that a buyer can acquire the debtor’s assets free and clear of virtually all liens, claims, and interests burdening the assets and the debtor. And when Section 363 is coupled with the “assumption and assignment” provisions of Section 365 of the Bankruptcy Code, a debtor is able to assign most contracts or leases that a buyer may wish to purchase, including contracts with ironclad anti-assignment language, provided that certain conditions are satisfied. When a target is experiencing severe financial distress, the benefit of acquiring assets “free and clear” is extraordinarily valuable.
363 Sales as a Health Care M&A Tool, Part 1 – Overview
July 28, 2020 | Blog | By Deborah Daccord, William Kannel, Tim McKeon
For those unfamiliar with 363 Sales, a 363 Sale couples a flexible and fast process with ample liability protection for willing buyers. The primary benefit to a 363 Sale is that a buyer can acquire the debtor’s assets free and clear of virtually all liens, claims and encumbrances burdening the assets and the debtor. When a target is experiencing severe financial distress, the benefit of acquiring assets “free and clear of all liens” is extraordinarily valuable.
News & Press
CaringBridge Names Deborah Daccord to its Board of Directors
January 24, 2023
Deborah Daccord Named to Elite List of 2021 BTI M&A Client Service All-Stars
September 09, 2021
Mintz Recognized by Chambers USA 2019
April 26, 2019
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 03, 2018
Mintz’s Deborah Daccord Named Among “Top Women of Law” by Massachusetts Lawyers Weekly
August 01, 2017
Events & Speaking
Leading Through a Crisis: COVID-19 Executive Idea Exchange Series
As Companies Working with Senior Populations, How are We Leading?
Webinar
WBL Board Program
Breaking Through to the Boardroom: Advice From Non-Traditional Board Candidates
Chicago, IL
Deborah is a nationally recognized leader in health industry transactions, focusing on complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.
Recognition & Awards
- BTI Consulting Group: M&A Client Service All-Star (2021)
- Best Lawyers in America: Health Care Law (2012 – 2023)
- Chambers USA: Massachusetts (Band 1) – Healthcare (2007 – 2018); (Band 2) - Healthcare (2019 – 2023)
- Nightingale’s Healthcare News: Outstanding Healthcare Transaction Lawyer (2009)
- Greater Boston Chamber of Commerce: Boston's Future Leaders (2006)
- Harvard Law School Irving Oberman Memorial Award
Deborah is a nationally recognized leader in health industry transactions, focusing on complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.
Involvement
- Managing Director, Golden Seeds
- Board of Trustees, Lasell Village
- Board Member, CaringBridge
- President’s Council and Past Board Chair, Big Sister Association of Greater Boston
- Founding Member, Women for Whittier
- Member, Women Business Leaders of the U.S. Health Care Industry Foundation
- Board of Visitors, Fenway Health
- Member, American Health Lawyers Association
- Member, Boston Bar Association
Recent Insights
Health Care Deal Structures: What Will the Deal Look Like?
February 15, 2023 |Blog
